Lantern Pharma(LTRN)
DALLAS, TX
PharmaceuticalFocus: Personalized cancer therapy
Lantern Pharma is a life sciences company focused on Personalized cancer therapy.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Phase 1
Clinical Trials (1)
NCT06132503Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
Phase 1Phase 1/2
Clinical Trials (1)
NCT07431216A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression
Phase 1/2LP-184
Advanced Solid TumorClinical Trials (1)
NCT05933265Study of LP-184 in Patients With Advanced Solid Tumors
Phase 1/2LP-300
Adenocarcinoma of LungClinical Trials (1)
NCT05456256A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Phase 2Phase 2
Clinical Trials (1)
NCT03643107Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)
Phase 2BNP7787
Breast NeoplasmsClinical Trials (1)
NCT00039780Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel
Phase 3Tavocept
Non-small Cell Lung CancerClinical Trials (1)
NCT00966914Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2007
Portfolio: 7 clinical trials
SEC Filings: 2 available